Sources | Names Used |
---|---|
CCLE, GDSC1000, FIMM | Nilotinib |
CTRPv2 | nilotinib |
PharmacoGx | Nilotinib |
Database | Identifier |
---|---|
Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
Pubchem: | 644241 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C5AR2 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | SEPT5 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0005 |
mRNA | MAP3K7 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | NDFIP1 | CCLE | pan-cancer | AAC | 0.18 | 0.0005 |
mRNA | IKZF3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
mRNA | PLCG2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
mRNA | CNR2 | CCLE | pan-cancer | AAC | -0.2 | 0.0005 |
mRNA | DUSP6 | CCLE | pan-cancer | AAC | 0.18 | 0.0005 |
mRNA | PTPRF | CCLE | pan-cancer | AAC | 0.27 | 0.0005 |
mRNA | ISG20 | CCLE | pan-cancer | AAC | -0.18 | 0.0005 |